Full-Time

Senior Viral Vector Bioprocess Engineer

Posted on 1/12/2023

Asimov

Asimov

51-200 employees

Provides tools for designing and manufacturing biological cells

Biotechnology

Senior

Dorchester, Boston, MA, USA

Requirements
  • 6+ years experience in upstream process development at a biopharma company or CDMO
  • Bachelor's or Master's degree in Chemical Engineering, Bioengineering, Biotechnology, or a related field. PhD is preferred but not required
  • Experience scaling-up an upstream mammalian cell culture process from benchtop to pilot or production-scale manufacturing
  • Deep mammalian cell culture expertise in AAV or lentivirus production
  • Experience working with shake flasks and small-scale automated bioreactors (e.g., AMBR15) in industry
  • Knowledge of regulatory filing requirements
  • Mastery of bioreactor operations including fed-batch and perfusion modes
  • Experience with statistical tools/DOE for experimental design or process optimization
  • Strong written and verbal communication skills
Responsibilities
  • Spearhead the roadmapping and development of mammalian bioreactor and upstream process infrastructure
  • Design and execute bioreactor and shake flasks experiments to develop mammalian cell culture processes for production of viral vectors
  • Lead upstream process scale-up with commercial partners
  • Be a technical resource within the Synthetic Biology team by mentoring junior peers and adjacent technical roles
  • Collaborate with the Automation and Software teams to develop automated systems for coordinating bioreactor runs and integrating process data into our computational platform
  • Communicate ideas, data, and strategy with other technical members, executives, and commercial partners
  • Organize and document experiments and data in an electronic lab notebook

Asimov's unique approach to biotechnology, integrating synthetic biology, computer-aided design, and machine learning, positions it as a leader in the design and manufacture of biologics and gene therapies. The company provides comprehensive support to its clients, offering both the tools for in-house cell line development and a service to create custom cell lines, demonstrating a commitment to flexibility and customer needs. Asimov's culture fosters interdisciplinary collaboration, driving technical advancements and enhancing its competitive edge in the biotech industry.

Company Stage

Series B

Total Funding

$204.7M

Headquarters

Boston, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

13%

1 year growth

35%

2 year growth

127%
INACTIVE